Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
|
|
50.
|
|
|
51.
|
|
|
52.
|
|
|
53.
|
Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. [electronic resource] by
- Koh, C
- Heller, T
- Haynes-Williams, V
- Hara, K
- Zhao, X
- Feld, J J
- Kleiner, D E
- Rotman, Y
- Ghany, M G
- Liang, T J
- Hoofnagle, J H
Producer: 20130917
In:
Alimentary pharmacology & therapeutics vol. 37
Availability: No items available.
|
|
54.
|
|
|
55.
|
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B. [electronic resource] by
- Ghany, M G
- Feld, J J
- Zhao, X
- Heller, T
- Doo, E
- Rotman, Y
- Nagabhyru, P
- Koh, C
- Kleiner, D E
- Wright, E C
- Liang, T J
- Hoofnagle, J H
Producer: 20141020
In:
Alimentary pharmacology & therapeutics vol. 35
Availability: No items available.
|
|
56.
|
Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. [electronic resource] by
- Takyar, V
- Etzion, O
- Heller, T
- Kleiner, D E
- Rotman, Y
- Ghany, M G
- Fryzek, N
- Williams, V H
- Rivera, E
- Auh, S
- Liang, T J
- Hoofnagle, J H
- Koh, C
Producer: 20170815
In:
Alimentary pharmacology & therapeutics vol. 45
Availability: No items available.
|
|
57.
|
Long-term therapy of chronic delta hepatitis with peginterferon alfa. [electronic resource] by
- Heller, T
- Rotman, Y
- Koh, C
- Clark, S
- Haynes-Williams, V
- Chang, R
- McBurney, R
- Schmid, P
- Albrecht, J
- Kleiner, D E
- Ghany, M G
- Liang, T J
- Hoofnagle, J H
Producer: 20140918
In:
Alimentary pharmacology & therapeutics vol. 40
Availability: No items available.
|
|
58.
|
Long-term therapy of chronic hepatitis B with lamivudine. [electronic resource] by
- Lau, D T
- Khokhar, M F
- Doo, E
- Ghany, M G
- Herion, D
- Park, Y
- Kleiner, D E
- Schmid, P
- Condreay, L D
- Gauthier, J
- Kuhns, M C
- Liang, T J
- Hoofnagle, J H
Producer: 20001019
In:
Hepatology (Baltimore, Md.) vol. 32
Availability: No items available.
|
|
59.
|
Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response. [electronic resource] by
- Rotman, Y
- Borg, B B
- Soza, A
- Feld, J J
- Modi, A A
- Loomba, R
- Lutchman, G
- Rivera, E
- Doo, E
- Ghany, M G
- Heller, T
- Neumann, A U
- Liang, T J
- Hoofnagle, J H
Producer: 20101105
In:
Alimentary pharmacology & therapeutics vol. 31
Availability: No items available.
|